Literature DB >> 15082768

Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer.

Tara J Moriarty1, Delphine T Marie-Egyptienne, Chantal Autexier.   

Abstract

Human telomerase is a multimer containing two human telomerase RNAs (hTRs) and most likely two human telomerase reverse transcriptases (hTERTs). Telomerase synthesizes multiple telomeric repeats using a unique repeat addition form of processivity. We investigated hTR and hTERT sequences that were essential for DNA synthesis and processivity using a direct primer extension telomerase assay. We found that hTERT consists of two physically separable functional domains, a polymerase domain containing RNA interaction domain 2 (RID2), reverse transcriptase (RT), and C-terminal sequences, and a major accessory domain, RNA interaction domain 1 (RID1). RID2 mutants defective in high-affinity hTR interactions and an RT catalytic mutant exhibited comparable DNA synthesis defects. The RID2-interacting hTR P6.1 helix was also essential for DNA synthesis. RID1 interacted with the hTR pseudoknot-template domain and hTERT's RT motifs and putative thumb and was essential for processivity, but not DNA synthesis. The hTR pseudoknot was essential for processivity, but not DNA synthesis, and processivity was reduced or abolished in dimerization-defective pseudoknot mutants. trans-acting hTERTs and hTRs complemented the processivity defects of RID1 and pseudoknot mutants, respectively. These data provide novel insight into the catalytic organization of the human telomerase complex and suggest that repeat addition processivity is one of the major catalytic properties conferred by telomerase multimerization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15082768      PMCID: PMC387747          DOI: 10.1128/MCB.24.9.3720-3733.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

1.  Telomeric repeat amplification, without shortening or lengthening of the telomerase products: a method to analyze the processivity of telomerase enzyme.

Authors:  I Szatmari; J Aradi
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

2.  Requirements for the dGTP-dependent repeat addition processivity of recombinant Tetrahymena telomerase.

Authors:  C D Hardy; C S Schultz; K Collins
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

3.  Analysis of telomerase processivity: mechanistic similarity to HIV-1 reverse transcriptase and role in telomere maintenance.

Authors:  Y Peng; I S Mian; N F Lue
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

4.  Human telomerase contains two cooperating telomerase RNA molecules.

Authors:  C Wenz; B Enenkel; M Amacker; C Kelleher; K Damm; J Lingner
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

5.  RNA binding domain of telomerase reverse transcriptase.

Authors:  C K Lai; J R Mitchell; K Collins
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

6.  Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions.

Authors:  F Bachand; C Autexier
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

7.  Essential functions of amino-terminal domains in the yeast telomerase catalytic subunit revealed by selection for viable mutants.

Authors:  K L Friedman; T R Cech
Journal:  Genes Dev       Date:  1999-11-01       Impact factor: 11.361

8.  The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.

Authors:  T Vulliamy; A Marrone; F Goldman; A Dearlove; M Bessler; P J Mason; I Dokal
Journal:  Nature       Date:  2001-09-27       Impact factor: 49.962

9.  Telomerase RNA bound by protein motifs specific to telomerase reverse transcriptase.

Authors:  T M Bryan; K J Goodrich; T R Cech
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

10.  Functional multimerization of the human telomerase reverse transcriptase.

Authors:  T L Beattie; W Zhou; M O Robinson; L Harrington
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

View more
  52 in total

1.  Human telomerase domain interactions capture DNA for TEN domain-dependent processive elongation.

Authors:  Aaron R Robart; Kathleen Collins
Journal:  Mol Cell       Date:  2011-04-21       Impact factor: 17.970

2.  A physical and functional constituent of telomerase anchor site.

Authors:  Neal F Lue
Journal:  J Biol Chem       Date:  2005-05-18       Impact factor: 5.157

3.  Telomerase can act as a template- and RNA-independent terminal transferase.

Authors:  Neal F Lue; Dimitry Bosoy; Tara J Moriarty; Chantal Autexier; Brian Altman; Siyang Leng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-30       Impact factor: 11.205

4.  Soluble domains of telomerase reverse transcriptase identified by high-throughput screening.

Authors:  Steven A Jacobs; Elaine R Podell; Deborah S Wuttke; Thomas R Cech
Journal:  Protein Sci       Date:  2005-08       Impact factor: 6.725

5.  Prediction of RNA binding sites in proteins from amino acid sequence.

Authors:  Michael Terribilini; Jae-Hyung Lee; Changhui Yan; Robert L Jernigan; Vasant Honavar; Drena Dobbs
Journal:  RNA       Date:  2006-06-21       Impact factor: 4.942

6.  hnRNP A1 associates with telomere ends and stimulates telomerase activity.

Authors:  Qing-Shuo Zhang; Lisa Manche; Rui-Ming Xu; Adrian R Krainer
Journal:  RNA       Date:  2006-04-07       Impact factor: 4.942

7.  The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase.

Authors:  Sophie Redon; Patrick Reichenbach; Joachim Lingner
Journal:  Nucleic Acids Res       Date:  2010-05-11       Impact factor: 16.971

8.  Human telomerase reverse transcriptase (hTERT) Q169 is essential for telomerase function in vitro and in vivo.

Authors:  Haley D M Wyatt; Allison R Tsang; Deirdre A Lobb; Tara L Beattie
Journal:  PLoS One       Date:  2009-09-24       Impact factor: 3.240

9.  A novel motif in telomerase reverse transcriptase regulates telomere repeat addition rate and processivity.

Authors:  Mingyi Xie; Joshua D Podlevsky; Xiaodong Qi; Christopher J Bley; Julian J-L Chen
Journal:  Nucleic Acids Res       Date:  2009-12-30       Impact factor: 16.971

10.  The N-terminus of hTERT contains a DNA-binding domain and is required for telomerase activity and cellular immortalization.

Authors:  David C F Sealey; Le Zheng; Michael A S Taboski; Jennifer Cruickshank; Mitsuhiko Ikura; Lea A Harrington
Journal:  Nucleic Acids Res       Date:  2009-12-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.